Expertise in
10
conditions

Nobuyuki Katakami

Takarazuka, JP 
Expertise in
10
conditions
Takarazuka, JP 

Overview

Nobuyuki Katakami practices practicing medicine in Takarazuka, Japan.

Mr. Katakami is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Paronychia.

He is actively involved in clinical research, co-authoring 150 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Takarazuka, 6650827, Japan
Other Locations
Kobe, Japan
Minamimachi, 6500047, Japan
Chuo, 6500047, Japan
Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3

150 Total Publications

Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomes.
Atezolizumab vs durvalumab for extensive-stage small cell lung cancer in Japan: a real-world comparative analysis of costs and clinical outcomes.
Journal: Japanese journal of clinical oncology
Published: April 29, 2026

Frequently Asked Questions about Nobuyuki Katakami

Is Nobuyuki Katakami a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Nobuyuki Katakami is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nobuyuki Katakami participate in research or clinical trials?

Yes. Nobuyuki Katakami has published 150 articles and abstracts on conditions like Lung Cancer. You can view a list of Nobuyuki Katakami's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Katakami's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile